Schrödinger to Participate in Five Upcoming Investor Conferences
Schrödinger (Nasdaq: SDGR) announced its participation in several upcoming investor conferences. Notable events include the 33rd Annual Piper Sandler Virtual Healthcare Conference, the 4th Annual Evercore ISI HealthCONx Conference on November 30, 2021, and the BMO 2021 Growth & ESG Conference on December 7, 2021. Management will also engage in one-on-one meetings during the Berenberg Discover AI Seminar 2021 on December 1. Interested parties can access both live and archived webcasts through the investors section of Schrödinger's website.
- None.
- None.
-
33rd Annual
Piper Sandler Virtual Healthcare Conference : A pre-recorded fireside chat will be available today after10:00 a.m. ET . -
4th Annual
Evercore ISI HealthCONx Conference : Management will participate in a fireside chat onTuesday, November 30, 2021 , at4:20 p.m. ET . -
BMO 2021
Growth & ESG Conference : A fireside chat will take place onTuesday, December 7 th at1:00 p.m. ET . -
Goldman Sachs Byte-ology: The Convergence of Biotechnology and Technology: A Biotech panel will take place on
Thursday, December 9, 2021 , at10:00 a.m. ET .
Additionally, the company will participate in one-on-one meetings during the Berenberg Discover AI Seminar 2021 on
The live and pre-recorded webcasts can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.
About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.
Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, our blog www.extrapolations.com, or follow us on LinkedIn and Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005950/en/
Schrödinger, Inc.
jaren.madden@schrodinger.com
617-286-6264
Schrödinger, Inc.
tracy.lessor@schrodinger.com
617-519-9827
Source: Schrödinger
FAQ
What investor conferences will Schrödinger (SDGR) participate in November 2021?
When is Schrödinger's fireside chat at the BMO 2021 Growth & ESG Conference?
How can I access the webcasts for Schrödinger's conferences?
What other events will Schrödinger participate in besides investor conferences?